Similar companies
| Company | Est. Net Value | |
|---|---|---|
 |
Gilead SciencesGILD |
$73,000 |
 |
AmgenAMGN |
$24,000 |
 |
BridgeBio PharmaBBIO |
$56,000 |
 |
Alnylam PharmaceuticalsALNY |
-$33,000 |
 |
GenprexGNPX |
$24,000 |
Are Members of Congress Buying or Selling TuHURA Biosciences?
No members of Congress have reported trading TuHURA Biosciences (HURA) stock in the past 90 days. The history below covers the past two years.
Congressional trading is one of the alternative data signals AltIndex tracks as part of the HURA AI Score. For corporate insider activity, see HURA insider transactions. To browse trades across every ticker, visit the Congress Trading tracker.
Which Congress Members Are Trading TuHURA Biosciences?
| Member of Congress | Activity | Trades | Last Trade |
|---|---|---|---|
| Laurel Lee | Bought $83,000 | 2 | Jul 13, 2025 |
HURA Congressional Trade History
| Member of Congress | Trade Date | Type | Estimated Size |
|---|---|---|---|
| Laurel Lee | Jul 13, 2025 | Buy | $50K – $100K |
| Laurel Lee | Nov 25, 2024 | Buy | $1K – $15K |
Frequently Asked Questions: TuHURA Biosciences Congress Trading
No members of Congress have reported buying or selling HURA stock in the past 90 days. Congressional trades are disclosed under the STOCK Act — view the full history on this page.
Some research has found that congressional stock trades have at times outperformed the market, possibly due to informational advantages. AltIndex tracks these trades as one of 25+ signals in the AI Score. See the full Congress Trading tracker for all recent trades.
Laurel Lee bought TuHURA Biosciences (HURA) stock most recently, on July 13, 2025.
The estimated net value of congressional trades in TuHURA Biosciences over the past 2 years is positive, at $83,000, meaning members of Congress have on balance bought more than they have sold.
Members of Congress can have early visibility into legislation, regulation, and government contracts that may affect a company. Tracking their disclosed trades — alongside other signals — can offer additional context for investment decisions.
